What is the treatment for ringworm (tinea infection)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Ringworm (Tinea Infections)

For tinea corporis and tinea cruris (body and groin ringworm), topical terbinafine 1% cream applied once or twice daily for 1-2 weeks is the most effective first-line treatment, providing superior cure rates compared to other topical agents. 1, 2

Topical Treatment Approach

First-Line Topical Agents

  • Terbinafine 1% cream is the preferred topical agent, applied once or twice daily for 1-2 weeks for tinea corporis and tinea cruris 1, 2, 3
  • Terbinafine demonstrates significantly higher mycological cure rates (93.5%) compared to clotrimazole (73.1%) and requires only 1 week of treatment versus 4 weeks for azoles 2
  • Naftifine 1% cream is an effective alternative, showing mycological cure rates 2.38 times higher than placebo 1

Alternative Topical Agents

  • Azole antifungals (clotrimazole, miconazole, ketoconazole) applied twice daily for 2-4 weeks are effective but require longer treatment duration 1, 3
  • Clotrimazole 1% demonstrates mycological cure rates 2.87 times higher than placebo 1
  • Butenafine cream is another inexpensive and effective option 4

Important Topical Treatment Considerations

  • Treatment should continue for at least 1 week after clinical clearing to prevent relapse 3
  • Topical therapy alone is not recommended for tinea capitis (scalp ringworm), which requires oral treatment 5
  • For tinea pedis (foot), treat for 4 weeks with azoles or 1-2 weeks with allylamines 3

Oral Treatment Approach

When to Use Oral Therapy

Oral antifungals are indicated for: 3, 4

  • Extensive disease covering large body surface areas
  • Failed topical treatment after 2-4 weeks
  • Tinea capitis (scalp infections) - always requires oral therapy
  • Immunocompromised patients
  • Severe or widespread infections

Oral Treatment Options

For Trichophyton species (most common): 5, 6

  • Terbinafine is first-line oral therapy
    • Adults >40 kg: 250 mg daily for 2-4 weeks 5, 6
    • Children 20-40 kg: 125 mg daily for 2-4 weeks 5
    • Children <20 kg: 62.5 mg daily for 2-4 weeks 5
  • Terbinafine is fungicidal with higher efficacy against Trichophyton species 6

For Microsporum species: 5, 7

  • Griseofulvin is the treatment of choice and the only licensed product for tinea capitis in children in the UK 5
    • Adults and children >50 lbs: 500 mg daily (or 250 mg twice daily) for 6-8 weeks 7
    • Children 30-50 lbs: 125-250 mg daily for 6-8 weeks 7
    • Standard dosing: 20 mg/kg daily for 6-8 weeks 5
  • Taking griseofulvin with fatty food increases absorption 5

Alternative oral agents: 5, 8

  • Itraconazole: 100 mg daily for 2-4 weeks, or 200 mg daily for 7 days 5, 8
  • Fluconazole: 50-100 mg daily or 150 mg once weekly for 2-3 weeks 5, 8

Treatment Failure Management

If initial treatment fails, consider: 5, 6

  • Lack of compliance with medication regimen
  • Suboptimal drug absorption
  • Organism resistance (rare)
  • Reinfection from contaminated sources

For clinical improvement but persistent positive mycology: Continue current therapy for an additional 2-4 weeks 5, 6

For no clinical improvement: Switch to second-line therapy 5, 6

  • If terbinafine failed for Trichophyton: switch to itraconazole 100 mg daily for 4 weeks 5
  • If griseofulvin failed for Microsporum: consider alternative agents 5

Prevention and Adjunctive Measures

  • Complete drying of affected areas after bathing is essential to prevent recurrence 9
  • Use separate towels for affected areas to reduce contamination 9
  • For anthropophilic species (human-to-human transmission), screen and treat family members and close contacts 5, 6
  • Antifungal shampoos (ketoconazole 2%, selenium sulfide 1%, or povidone-iodine) reduce spore transmission for scalp infections 5
  • Clean contaminated personal items with disinfectant 6
  • Avoid sharing personal items and skin-to-skin contact with infected individuals 6

Common Pitfalls to Avoid

  • Do not use topical therapy alone for tinea capitis - oral treatment is mandatory 5
  • Do not use terbinafine for tinea versicolor - it is ineffective for this condition 8
  • Griseofulvin is not effective for tinea versicolor, candidiasis, or other non-dermatophyte infections 7
  • Avoid premature discontinuation - treatment must continue until mycological cure is achieved, not just clinical improvement 7
  • Combination steroid-antifungal creams may provide faster symptom relief but are not recommended in guidelines due to potential steroid complications 1, 3

Follow-Up and Monitoring

  • The endpoint of treatment is mycological cure (negative microscopy and culture), not just clinical improvement 5, 6
  • Repeat mycology sampling is recommended until mycological clearance is documented 5, 6
  • For tinea capitis, treatment duration is typically 4-6 weeks; for tinea corporis, 2-4 weeks 7

References

Research

Topical antifungal treatments for tinea cruris and tinea corporis.

The Cochrane database of systematic reviews, 2014

Research

Topical treatment of common superficial tinea infections.

American family physician, 2002

Research

Diagnosis and management of tinea infections.

American family physician, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Tinea Barbae

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral therapy of common superficial fungal infections of the skin.

Journal of the American Academy of Dermatology, 1999

Guideline

Treatment of Tinea Versicolor

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.